Evidence map›Paper›PMID 42029937›Full record

ReviewJournal of cancer research and clinical oncology2026

Castleman disease arising from the pleura: a case report and literature review.

Hao Yang, Mingjie Ning, Pengyu Li, Jing Qiu, Yu Huang, Ying Chen

Abstract readCase ReportsReview
In one paragraph

Review in Journal of cancer research and clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hao Yang *Department of Thoracic Surgery I, Yunnan Cancer Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, No. 519 Kunzhou Road, Kunming, 650118, China.
Mingjie Ning *Department of Thoracic Surgery I, Yunnan Cancer Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, No. 519 Kunzhou Road, Kunming, 650118, China.
Pengyu LiDepartment of Thoracic Surgery I, Yunnan Cancer Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, No. 519 Kunzhou Road, Kunming, 650118, China.
Jing QiuDepartment of Thoracic Surgery I, Yunnan Cancer Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, No. 519 Kunzhou Road, Kunming, 650118, China.
Yu HuangDepartment of Hepatobiliary and Pancreatic Surgery, Yunnan Cancer Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, No. 519 Kunzhou Road, Kunming, 650118, China. 463895659@QQ.com.CN.
Ying ChenDepartment of Thoracic Surgery I, Yunnan Cancer Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, No. 519 Kunzhou Road, Kunming, 650118, China. Chenying12@kmmu.edu.cn.

Funding

Development of Precision Prevention and Full-Cycle Intelligent Management System for Regionally High-Incidence Lung Cancer in Yunnan 202303AC100203"First-Class Discipline Team Construction Project" of Kunming Medical University for the Environmental, Genetic, and Lung Cancer Pathogenesis Research Team 2024XKTDPY07,2024XKTDYS07Key Technologies Research and Development Program 202403AC100015National Aerospace Science Foundation of China 82060426,82272980,82360562Yunnan Provincial Chest Tumor Prevention and Treatment Research Innovation Team 202405AS350015
6 · The paper itself

Abstract

backgroundCastleman disease (CD) is a rare lymphoproliferative disorder that commonly involves the abdomen, head and neck, and mediastinum. Primary involvement of the pleura is rare and prone to misdiagnosis. CASE PRESENTATION: We report the case of an asymptomatic 58-year-old male presenting with an incidental left pleural mass detected during a physical examination. While imaging studies initially suggested a solitary fibrous tumor or vascular neoplasm, definitive diagnosis of pleural hyaline vascular unicentric Castleman disease (UCD) was confirmed via pathological and immunohistochemical evaluation following surgical resection. The patient exhibited a favorable recovery after the surgical intervention.

conclusionBased on this case and literature review, the disease predominantly affects young to middle-aged individuals and seems to have no significant gender predilection. About half of patients with pleural UCD present with clinical symptoms, a relatively high proportion. Imaging and laboratory tests have limited diagnostic value for this condition, definitive diagnosis relies on histopathological examination, and surgical resection typically leads to a favorable prognosis. It is recommended to consider rare diseases such as CD in the differential diagnosis of pleural masses.

Indexed as

Castleman DiseasePleuraPleural DiseasesPleural NeoplasmsHumansMaleMiddle AgedCase reportHistopathologyPleuraSurgical treatmentUnicentric Castleman disease

Identifiers

PMID42029937
PMCPMC13109541

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.